The integration of Sortilin, HMGB1, and GALP into a first-trimester predictive panel (AUC 0.84) enables a paradigm shift from reactive GDM diagnosis to proactive prevention in PCOS pregnancies. Here, HMGB1 is linked to polycystic ovary syndrome.